Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Oct;82(4):1353-8.
doi: 10.1172/JCI113738.

Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency

Affiliations

Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency

A Maddalena et al. J Clin Invest. 1988 Oct.

Abstract

Point mutations in the X-linked ornithine transcarbamylase (OTC) gene have been detected at the same Taq I restriction site in 3 of 24 unrelated probands with OTC deficiency. A de novo mutation could be traced in all three families to an individual in a prior generation, confirming independent recurrence. The DNA sequence in the region of the altered Taq I site was determined in the three probands. In two unrelated male probands with neonatal onset of severe OTC deficiency, a guanine (G) to adenine (A) mutation on the sense strand (antisense cytosine [C] to thymine [T]) was found, resulting in glutamine for arginine at amino acid 109 of the mature polypeptide. In the third case, where the proband was a symptomatic female, C to T (sense strand) transition converted residue 109 to a premature stop. These results support the observation that Taq I restriction sites, which contain an internal CG, are particularly susceptible to C to T transition mutation due to deamination of a methylated C in either the sense or antisense strand. The OTC gene seems especially sensitive to C to T transition mutation at arginine codon 109 because either a nonsense mutation or an extremely deleterious missense mutation will result.

PubMed Disclaimer

References

    1. J Biol Chem. 1980 Aug 10;255(15):7287-90 - PubMed
    1. Methods Enzymol. 1987;152:447-51 - PubMed
    1. Biochim Biophys Acta. 1982 May 21;704(1):100-6 - PubMed
    1. Science. 1983 Oct 28;222(4622):426-8 - PubMed
    1. Cell. 1984 Jan;36(1):131-8 - PubMed

Publication types